Free Trial

Immuneering (IMRX) SEC Filings & 10K Form

Immuneering logo
$3.39 -0.20 (-5.57%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$3.38 -0.02 (-0.44%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Immuneering SEC Filings

DateFilerForm TypeView
07/03/2025
8:12 AM
Immuneering (Issuer)
Zeskind Benjamin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
8:09 AM
Immuneering (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
7:52 AM
Brakewood Harold Eugene (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
8:01 AM
Hall Brett Matthew (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
8:09 AM
Feinberg Peter (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
5:30 AM
Immuneering (Filer)
Form 424B5
06/20/2025
8:09 AM
Immuneering (Issuer)
Zeskind Benjamin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
8:11 AM
Immuneering (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025
5:09 AM
Immuneering (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
7:59 AM
CARPENTER ROBERT J (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
8:04 AM
Feinberg Peter (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
8:09 AM
Immuneering (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
8:15 AM
Immuneering (Issuer)
Schall Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
8:21 AM
HAUSMAN DIANA (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:44 AM
Immuneering (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
7:54 AM
BERMAN ANN E (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:34 PM
Immuneering (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2025
3:16 PM
Immuneering (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/05/2025
3:17 PM
Immuneering (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
3:50 PM
Immuneering (Filer)
Form DEF 14A
04/21/2025
3:56 PM
Immuneering (Filer)
Form DEFA14A
03/24/2025
3:12 PM
Immuneering (Issuer)
Matushansky Igor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:47 PM
Immuneering (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
3:07 PM
Immuneering (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:06 PM
Bookman Michael (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:10 PM
Immuneering (Issuer)
Zeskind Benjamin J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:36 PM
Immuneering (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
7:26 AM
Immuneering (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:12 PM
Feinberg Peter (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:19 PM
BERMAN ANN E (Reporting)
Immuneering (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:06 PM
Immuneering (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
2:03 PM
Cormorant Asset Management, LP (Filed by)
Immuneering (Subject)
Form SC 13G/A
09/12/2024
3:11 PM
Immuneering (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMRX) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners